Louisiana Funds — Full Portfolio
18 tracked investments · listed companies and verified rows first
Bioceptive develops women's health medical devices, including a patented FDA-approved Cervical Suction Retractor that replaces the tenaculum for gynecological procedures and an IUD inserter, offering single-use disposable instruments aimed at reducing pain during transcervical procedures.
BiotechFemTechHealthtechMedical DevicesNew Orleans, US
Stewart Davis(Executive Officer, Director)Shuchi Khurana(Executive Officer)Benjamin Cappiello(Executive Officer, Director)
BoardJoan Neuscheler(Director)Joseph Lovett(Director)inAmit Kumar Rathi(Director)
Co-investorsNew Orleans Startup FundNew World Angels
Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement.
Austin, US
John Wheeler(Executive Officer, Director)Joe Cunningham(Director)David Adair(Director)David Strong(Director)
Co-investorsRex Health VenturesOrlando Health Ventures
Developing intra-articular ion channel modulator therapeutics for osteoarthritis of the knee.
BiotechShreveport, US
William R. Grimes(President and Chief Executive Officer)Stephen Snowdy(Executive Officer, Director)David Waddell(Director)
BoardJoseph Lovett(Director)inRichard Babb(Treasurer)inMike Sherman(Director)
Dowley Security Systems is a full-service security integrator that designs, installs, monitors, and maintains integrated security solutions for organizations in education, government, and commercial markets.
AI & Machine LearningCybersecurityEnterprise SoftwareHardwareHouston, US
Mark Davis(President & Chief Executive Officer)in
Clinical-stage specialty pharma developing a combination drug to treat a range of addictions, licensed from LSU Health Sciences Center.
BiotechSudbury, US
Robert B. Linke(Executive Officer, Director)
BoardRoss Barrett(Director)Franz Hefti(Director)John Beaird(Director)Joseph Lovett(Director)
Co-investorsInnovation CatalystKeiretsu ForumKeiretsu Capital
Esperance develops targeted oncology therapeutics designed to selectively kill cancer cells, including chemotherapy-resistant cells, via a proprietary Cationic Lytic Peptide (CLYP) platform, membrane-disrupting peptides, and antibody drug conjugates.
BiotechHealthtechHouston, US
Hector Alila(Executive Officer, Director)Ross Barrett(Director)Peter Hoang(Director)Sonia Deggs(Executive Officer)Carola Leuschner(Executive Officer)
BoardJoseph Lovett(Director)in
Co-investorsResearch Corporation Technologies
Compact micro-tube heat exchanger technology for high-end thermal management in propulsion, electronics, and cooling applications.
Mirata Pharmaceuticals is developing pain-relieving drugs intended to provide the analgesic benefits of opioids without their addictive properties and serious side effects.
BiotechHealthtechPlymouth Meeting, US
John Johnson(Director)Brian Hubbard(Director)Jason Y Zhang(Director)Maurits Geerlings(Director)Matthew Callahan(Executive Officer, Director)
BoardJoseph F Lovett(Director)in
Developing 'Epi-drugs' that modulate epigenetic targets for cancer and other diseases.
BiotechBaton Rouge, US
Kenneth J Eilertsen(Director)in
BoardJoan P Neuscheler(Executive Officer, Director)Ross Barrett(Director)Charles Oehler(Director)Joseph F Lovett(Executive Officer, Director)in
Omnidek offers a business portal that connects to Sage Intacct to synchronize data and provides a library of configurable workflow and process widgets.
Enterprise SoftwareFuture of WorkSaaSBaton Rouge, US
HUEY NGO(Director)inAJOY KRISHNAMOORTHY(Director)STEVEN CHRISTOPHER JORDAN(Executive Officer, Director)
BoardRICHARD BABB(Director)inWILLIAM ELLISON(Director)in
Co-investorsInnovation Catalyst
PRECISIS develops bioelectronic therapies for neurological conditions, including EASEE, a minimally invasive neurostimulation system implanted under the scalp to treat drug-resistant focal epilepsy without brain surgery.
HardwareHealthtechMedical DevicesHeidelberg, DE
Co-investorsEuropean Investment Bank
Provides solutions for stem cell maintenance, proliferation, differentiation, and large-scale production, including recombinant substrates and antibodies.
Qure4u offers an AI-powered patient engagement platform that automates workflows for healthcare providers, including self-scheduling, digital check-in, arrivals, payment collection, and remote patient monitoring.
Digital HealthHealthtechSaaSBradenton, US
Monica Bolbjerg(Founder)inTorsten Bolbjerg(Co-founder)in
Co-investorsAtlanta Technology AngelsNew World AngelsSaaS CapitalVolition Capital
Servato develops hardware, software, and predictive analytics for critical infrastructure monitoring and maintenance, including a Platform-as-a-Service that predicts system failures and an Adaptive Charging feature that extends telecom battery life.
EnergyHardwareIoTSaaSNew Orleans, US
MARK CHRISTOPHER MANGUM(Executive Officer, Director)Ronald Lau(Executive Officer)Chris Mangum(President & CEO)inEric Hedlund(Chief Sales Officer)inDorion Carr(Chief Technology Officer)Roy Clingman(Chief Business Development Officer)in
Co-investorsNew Orleans Startup FundVenture Center Arkansas
BiotechBoulder, US
Harry Ross(Executive Officer, Director)Donald Schomer(Director)Robert Di Scipio(Director)Mark Lupa(Director)Jesse Aweida(Director)
BoardDan Watkins(Director)
Co-investorsCreathor VenturesMercury Fund
TESA Medical operates an online platform listing medical products from brand manufacturers, offering direct sales, consignment, wholesale, retail, and OEM options.
B2B MarketplacesHealthtechMedical Devices
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Corcym
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


















